Insider · CIK 0001533149

Upadhyay Suketu

Reports to the SEC for 6 companies · WILMINGTON, DE

sec.gov

Transactions

Companies

Filings

CIK

0001533149

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-04	INCYINCYTE CORPA Award	EVP & Chief Financial Officer	AAward	+26.3K sh	—	—	26,343
2026-05-04	INCYINCYTE CORP · Employee Stock Option (right to buy)A Award	EVP & Chief Financial Officer	AAward	+38.4K sh	—	—	38,429
2026-05-04	INCYINCYTE CORP · Performance SharesA Award	EVP & Chief Financial Officer	AAward	+13.2K sh	—	—	26,342
2026-05-01	VRTXVERTEX PHARMACEUTICALS INC / MAD Disposition to Issuer	Director	DDisposition to Issuer	−796 sh	—	—	1,558
2026-05-01	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)A Award	Director	AAward	+2,866 sh	—	—	2,866
2026-05-01	VRTXVERTEX PHARMACEUTICALS INC / MA · Deferred Stock UnitsA Award	Director	AAward	+796 sh	—	—	3,595.156
2026-04-15	VRTXVERTEX PHARMACEUTICALS INC / MA · Deferred Stock UnitsA Award	Director	AAward	+80.508 sh	$442.50	+$35.6K	2,799.156
2026-03-06	ZBHZIMMER BIOMET HOLDINGS, INC.M Exercise/Conversion	Exec VP, CFO	MExercise/Conversion	+10.2K sh	—	—	71,502
2026-03-06	ZBHZIMMER BIOMET HOLDINGS, INC.F Tax Payment	Exec VP, CFO	FTax Payment	−4,547 sh	$92.54	−$421K	66,955
2026-03-06	ZBHZIMMER BIOMET HOLDINGS, INC.M Exercise/Conversion	Exec VP, CFO	MExercise/Conversion	+4,559 sh	—	—	71,514
2026-03-06	ZBHZIMMER BIOMET HOLDINGS, INC.F Tax Payment	Exec VP, CFO	FTax Payment	−2,029 sh	$92.54	−$188K	69,485
2026-03-06	ZBHZIMMER BIOMET HOLDINGS, INC. · Restricted Stock UnitsM Exercise/Conversion	Exec VP, CFO	MExercise/Conversion	−10.2K sh	—	—	0
2026-03-06	ZBHZIMMER BIOMET HOLDINGS, INC. · Restricted Stock UnitsM Exercise/Conversion	Exec VP, CFO	MExercise/Conversion	−4,559 sh	—	—	0
2026-02-25	ZBHZIMMER BIOMET HOLDINGS, INC.M Exercise/Conversion	Exec VP, CFO	MExercise/Conversion	+6,364 sh	—	—	64,117
2026-02-25	ZBHZIMMER BIOMET HOLDINGS, INC.F Tax Payment	Exec VP, CFO	FTax Payment	−2,832 sh	$99.51	−$282K	61,285
2026-02-25	ZBHZIMMER BIOMET HOLDINGS, INC. · Restricted Stock UnitsM Exercise/Conversion	Exec VP, CFO	MExercise/Conversion	−6,364 sh	—	—	12,726
2026-02-20	ZBHZIMMER BIOMET HOLDINGS, INC.M Exercise/Conversion	Exec VP, CFO	MExercise/Conversion	+5,445 sh	—	—	60,199
2026-02-20	ZBHZIMMER BIOMET HOLDINGS, INC.F Tax Payment	Exec VP, CFO	FTax Payment	−2,446 sh	$98.62	−$241K	57,753
2026-02-20	ZBHZIMMER BIOMET HOLDINGS, INC. · Restricted Stock UnitsM Exercise/Conversion	Exec VP, CFO	MExercise/Conversion	−5,445 sh	—	—	5,445
2026-02-20	ZBHZIMMER BIOMET HOLDINGS, INC. · Restricted Stock UnitsA Award	Exec VP, CFO	AAward	+21.7K sh	—	—	21,701
2026-02-19	ZBHZIMMER BIOMET HOLDINGS, INC. · Restricted Stock UnitsA Award	Exec VP, CFO	AAward	+10.2K sh	—	—	10,217
2026-01-15	VRTXVERTEX PHARMACEUTICALS INC / MA · Deferred Stock UnitsA Award	Director	AAward	+80.316 sh	$443.56	+$35.6K	2,718.648
2025-11-10	ZBHZIMMER BIOMET HOLDINGS, INC.M Exercise/Conversion	Exec VP, CFO	MExercise/Conversion	+10.6K sh	—	—	59,485
2025-11-10	ZBHZIMMER BIOMET HOLDINGS, INC.F Tax Payment	Exec VP, CFO	FTax Payment	−4,731 sh	$87.73	−$415K	54,754
2025-11-10	ZBHZIMMER BIOMET HOLDINGS, INC. · Restricted Stock UnitsM Exercise/Conversion	Exec VP, CFO	MExercise/Conversion	−10.6K sh	—	—	0
2025-10-24	ZBHZIMMER BIOMET HOLDINGS, INC. · Restricted Stock UnitsA Award	Exec VP, CFO	AAward	+10.6K sh	—	—	10,632
2025-10-15	VRTXVERTEX PHARMACEUTICALS INC / MA · Deferred Stock UnitsA Award	Director	AAward	+86.825 sh	$410.31	+$35.6K	2,638.332
2025-07-15	VRTXVERTEX PHARMACEUTICALS INC / MA · Deferred Stock UnitsA Award	Director	AAward	+75.904 sh	$469.34	+$35.6K	2,551.507
2025-05-01	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	Director	AAward	+796 sh	—	—	3,355
2025-05-01	VRTXVERTEX PHARMACEUTICALS INC / MAD Disposition to Issuer	Director	DDisposition to Issuer	−1,001 sh	—	—	2,354
2025-05-01	VRTXVERTEX PHARMACEUTICALS INC / MA · Deferred Stock UnitsA Award	Director	AAward	+1,001 sh	—	—	2,475.603
2025-04-15	VRTXVERTEX PHARMACEUTICALS INC / MA · Deferred Stock UnitsA Award	Director	AAward	+71.607 sh	$497.51	+$35.6K	1,474.603
2025-03-06	ZBHZIMMER BIOMET HOLDINGS, INC.M Exercise/Conversion	Exec VP, CFO	MExercise/Conversion	+4,560 sh	—	—	50,882
2025-03-06	ZBHZIMMER BIOMET HOLDINGS, INC.F Tax Payment	Exec VP, CFO	FTax Payment	−2,029 sh	$104.86	−$213K	48,853
2025-03-06	ZBHZIMMER BIOMET HOLDINGS, INC. · Restricted Stock UnitsM Exercise/Conversion	Exec VP, CFO	MExercise/Conversion	−4,560 sh	—	—	4,559
2025-02-25	ZBHZIMMER BIOMET HOLDINGS, INC. · Restricted Stock UnitsA Award	Exec VP, CFO	AAward	+19.1K sh	—	—	19,090
2025-02-20	ZBHZIMMER BIOMET HOLDINGS, INC.M Exercise/Conversion	Exec VP, CFO	MExercise/Conversion	+5,446 sh	—	—	48,745
2025-02-20	ZBHZIMMER BIOMET HOLDINGS, INC.F Tax Payment	Exec VP, CFO	FTax Payment	−2,423 sh	$103.46	−$251K	46,322
2025-02-20	ZBHZIMMER BIOMET HOLDINGS, INC. · Restricted Stock UnitsM Exercise/Conversion	Exec VP, CFO	MExercise/Conversion	−5,446 sh	—	—	10,890
2025-02-18	ZBHZIMMER BIOMET HOLDINGS, INC.M Exercise/Conversion	Exec VP, CFO	MExercise/Conversion	+21.6K sh	—	—	51,454
2025-02-18	ZBHZIMMER BIOMET HOLDINGS, INC.F Tax Payment	Exec VP, CFO	FTax Payment	−8,155 sh	$101.00	−$824K	43,299
2025-02-18	ZBHZIMMER BIOMET HOLDINGS, INC. · Restricted Stock UnitsM Exercise/Conversion	Exec VP, CFO	MExercise/Conversion	−21.6K sh	—	—	0
2025-02-14	ZBHZIMMER BIOMET HOLDINGS, INC. · Restricted Stock UnitsA Award	Exec VP, CFO	AAward	+21.6K sh	—	—	21,622
2024-11-10	ZBHZIMMER BIOMET HOLDINGS, INC.M Exercise/Conversion	Exec VP, CFO	MExercise/Conversion	+15.9K sh	—	—	36,842
2024-11-10	ZBHZIMMER BIOMET HOLDINGS, INC.F Tax Payment	Exec VP, CFO	FTax Payment	−7,097 sh	$108.48	−$770K	29,745
2024-11-10	ZBHZIMMER BIOMET HOLDINGS, INC. · Restricted Stock UnitsM Exercise/Conversion	Exec VP, CFO	MExercise/Conversion	−15.9K sh	—	—	0
2024-11-08	ZBHZIMMER BIOMET HOLDINGS, INC. · Restricted Stock UnitsA Award	Exec VP, CFO	AAward	+15.9K sh	—	—	15,948
2024-05-01	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	Director	AAward	+1,001 sh	—	—	3,727
2024-05-01	VRTXVERTEX PHARMACEUTICALS INC / MAD Disposition to Issuer	Director	DDisposition to Issuer	−1,168 sh	—	—	2,559
2024-05-01	VRTXVERTEX PHARMACEUTICALS INC / MA · Deferred Stock UnitsA Award	Director	AAward	+1,168 sh	—	—	1,402.996

Recent filings

Accepted (ET)
May 64
Upadhyay Suketu0001533149-26-000014
SEC(opens sec.gov)
May 54
Upadhyay Suketu0000875320-26-000193
SEC(opens sec.gov)
Apr 174
Upadhyay Suketu0000875320-26-000163
SEC(opens sec.gov)
Mar 104
Upadhyay Suketu0001533149-26-000009
SEC(opens sec.gov)
Feb 274
Upadhyay Suketu0001533149-26-000007
SEC(opens sec.gov)
Feb 244
Upadhyay Suketu0001533149-26-000005
SEC(opens sec.gov)

Companies

Address

1801 AUGUSTINE CUT-OFF

WILMINGTON, DE, 19803